Advanced search
Publication Cover
Current Medical Research and Opinion Volume 39, 2023 - Issue 3
Submit an article Journal homepage
2,400
Views
6
CrossRef citations to date
0
Altmetric
Psychiatry

Challenges in the clinical development of non-D2 compounds for schizophrenia

Seth C. HopkinsSunovion Pharmaceuticals Inc, Marlborough, MA, USACorrespondence[email protected]
,
Robert LewSunovion Pharmaceuticals Inc, Marlborough, MA, USA
,
Courtney ZeniSunovion Pharmaceuticals Inc, Marlborough, MA, USA
&
Kenneth S. KoblanSunovion Pharmaceuticals Inc, Marlborough, MA, USA
Pages 467-471 | Received 23 Aug 2022, Accepted 10 Nov 2022, Published online: 25 Nov 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.